Your browser is no longer supported. Please, upgrade your browser.
Settings
DVA [NYSE]
DaVita Inc.
IndexS&P 500 P/E14.62 EPS (ttm)7.67 Insider Own0.50% Shs Outstand106.36M Perf Week-0.89%
Market Cap11.89B Forward P/E11.56 EPS next Y9.71 Insider Trans-13.31% Shs Float101.67M Perf Month-7.46%
Income883.30M PEG0.84 EPS next Q2.26 Inst Own90.20% Short Float2.69% Perf Quarter-4.76%
Sales11.57B P/S1.03 EPS this Y39.30% Inst Trans0.13% Short Ratio4.25 Perf Half Y1.29%
Book/sh12.01 P/B9.34 EPS next Y5.52% ROA5.00% Target Price142.88 Perf Year26.21%
Cash/sh10.20 P/C11.01 EPS next 5Y17.33% ROE63.00% 52W Range84.14 - 136.48 Perf YTD-4.42%
Dividend- P/FCF10.58 EPS past 5Y38.60% ROI13.60% 52W High-17.78% Beta1.28
Dividend %- Quick Ratio1.60 Sales past 5Y-3.50% Gross Margin31.40% 52W Low33.36% ATR2.55
Employees67000 Current Ratio1.70 Sales Q/Q1.30% Oper. Margin14.40% RSI (14)31.70 Volatility2.16% 2.15%
OptionableYes Debt/Eq7.03 EPS Q/Q62.30% Profit Margin7.50% Rel Volume1.06 Prev Close111.47
ShortableYes LT Debt/Eq6.89 EarningsAug 03 AMC Payout0.00% Avg Volume644.00K Price112.21
Recom3.00 SMA20-4.02% SMA50-10.05% SMA200-4.97% Volume682,525 Change0.66%
Sep-10-21Initiated Cowen Market Perform $145
Aug-12-21Downgrade Barclays Overweight → Equal Weight $135 → $146
Mar-26-21Downgrade BofA Securities Neutral → Underperform $127 → $118
Jan-05-21Downgrade BofA Securities Buy → Neutral $127
Jan-24-20Upgrade Goldman Neutral → Buy $72 → $97
Nov-07-19Downgrade Raymond James Outperform → Mkt Perform
Oct-25-19Downgrade Wolfe Research Outperform → Peer Perform
Sep-11-19Downgrade William Blair Outperform → Mkt Perform
Jul-26-19Downgrade Robert W. Baird Outperform → Neutral $70 → $65
Jan-08-19Upgrade UBS Sell → Neutral
Jan-03-19Initiated Deutsche Bank Buy $60
Dec-14-18Initiated Barclays Overweight
Nov-28-18Upgrade Raymond James Mkt Perform → Outperform
Nov-16-18Initiated UBS Sell $64
Nov-08-18Downgrade Raymond James Strong Buy → Mkt Perform
Sep-13-18Upgrade JP Morgan Underweight → Neutral
Jan-04-18Upgrade BofA/Merrill Neutral → Buy
Dec-12-17Upgrade Robert W. Baird Neutral → Outperform $63 → $82
Dec-11-17Upgrade Citigroup Neutral → Buy
Dec-07-17Upgrade Raymond James Outperform → Strong Buy
Oct-14-21 12:24PM  
Oct-12-21 07:46PM  
Oct-11-21 09:18AM  
06:02AM  
Oct-01-21 11:22AM  
Sep-28-21 08:11AM  
Sep-16-21 06:02AM  
Sep-10-21 07:13AM  
Sep-09-21 04:02PM  
08:00AM  
Sep-02-21 11:31AM  
Aug-19-21 12:18PM  
Aug-11-21 07:00AM  
Aug-10-21 09:37AM  
Aug-05-21 11:50AM  
Aug-04-21 01:12PM  
10:30AM  
Aug-03-21 08:31PM  
06:05PM  
04:05PM  
Jul-30-21 03:44AM  
Jul-28-21 11:29AM  
Jul-27-21 03:02PM  
Jul-25-21 09:57PM  
Jul-21-21 04:00AM  
Jul-16-21 06:50AM  
Jul-15-21 05:47PM  
04:48PM  
Jul-06-21 07:57AM  
Jul-02-21 07:22AM  
Jun-29-21 08:25AM  
Jun-23-21 09:42AM  
Jun-21-21 11:40AM  
09:07AM  
Jun-18-21 10:41AM  
08:24AM  
Jun-17-21 11:45AM  
10:58AM  
Jun-14-21 08:37AM  
07:16AM  
Jun-11-21 09:06AM  
Jun-10-21 08:04AM  
06:45AM  
Jun-08-21 11:46AM  
Jun-07-21 10:29AM  
Jun-04-21 11:40AM  
Jun-02-21 06:07AM  
May-31-21 10:45AM  
May-26-21 08:07AM  
May-19-21 11:40AM  
May-13-21 06:02AM  
May-12-21 11:21AM  
May-10-21 07:35AM  
06:01AM  
May-07-21 08:58AM  
Apr-30-21 12:50PM  
05:31AM  
Apr-29-21 05:45PM  
04:05PM  
02:45PM  
Apr-27-21 06:02AM  
Apr-26-21 12:43PM  
Apr-24-21 07:18AM  
Apr-22-21 04:05PM  
Apr-19-21 04:35PM  
Apr-14-21 02:41AM  
Apr-12-21 10:00AM  
Mar-29-21 09:00AM  
06:05AM  
Mar-26-21 02:06PM  
12:45PM  
Mar-25-21 11:00AM  
Mar-23-21 08:00AM  
Mar-18-21 11:04AM  
Mar-16-21 08:00AM  
Mar-15-21 02:32AM  
Mar-13-21 10:30AM  
Mar-09-21 03:00AM  
Mar-02-21 07:00AM  
Feb-24-21 06:00PM  
07:44AM  
Feb-23-21 06:13PM  
Feb-18-21 03:37AM  
Feb-13-21 01:32AM  
Feb-12-21 11:47AM  
08:53AM  
Feb-11-21 09:31PM  
05:25PM  
04:47PM  
04:06PM  
03:15PM  
Feb-10-21 10:36AM  
Feb-06-21 08:52PM  
Feb-05-21 10:52AM  
Jan-29-21 05:47AM  
Jan-28-21 06:34AM  
Jan-20-21 07:47AM  
Jan-05-21 12:18PM  
09:59AM  
06:00AM  
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure or end stage renal disease (ESRD). The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company provides disease management services; vascular access services; clinical research programs; physician services; and comprehensive care services. As of December 31, 2020, it provided dialysis and administrative services in the United States through a network of 2,816 outpatient dialysis centers serving approximately 204,200 patients; and operated 321 outpatient dialysis centers located in 10 countries outside of the United States serving approximately 36,700 patients. Further, the company provides acute inpatient dialysis services in approximately 900 hospitals and related laboratory services in the United States. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
STAFFIERI MICHAEL DAVIDChief Operating Officer, DKCSep 03Option Exercise65.4837,1012,429,373117,783Sep 08 05:59 PM
Arway Pamela MDirectorAug 23Sale133.0936548,57819,239Aug 23 06:08 PM
ACKERMAN JOELCFO and TreasuerAug 09Option Exercise68.89145,15910,000,004180,659Aug 11 07:32 PM
Price Paula ADirectorAug 05Sale132.66790104,804380Aug 06 06:00 PM
ACKERMAN JOELCFO & TreasurerAug 05Sale131.3637,7604,960,14635,500Aug 06 06:00 PM
YALE PHYLLIS RDirectorJun 22Option Exercise70.9511,757834,14518,414Jun 23 07:02 PM
YALE PHYLLIS RDirectorJun 22Sale124.335,048627,6019,546Jun 23 07:02 PM
Arway Pamela MDirectorMay 24Sale123.1237946,66219,239May 25 05:31 PM
DESOER BARBARA JDirectorMay 13Option Exercise75.775,015379,9875,015May 17 06:25 PM
DESOER BARBARA JDirectorMay 13Sale126.011,920241,9450May 17 06:25 PM
Rodriguez JavierChief Executive OfficerMay 05Option Exercise75.42124,0919,358,943397,716May 05 08:09 PM
NEHRA JOHN MDirectorMay 05Option Exercise75.775,015379,9875,015May 05 08:10 PM
Rodriguez JavierChief Executive OfficerMay 05Sale122.2227,0533,306,548273,625May 05 08:09 PM
HEARTY JAMES OChief Compliance OfficerMay 04Option Exercise75.423,308249,48916,874May 05 08:10 PM
BERG CHARLESDirectorMay 04Option Exercise75.775,015379,98717,463May 05 08:10 PM
BERG CHARLESDirectorMay 04Sale122.521,872229,35712,448May 05 08:10 PM
HEARTY JAMES OChief Compliance OfficerMay 04Sale121.89884107,74613,566May 05 08:10 PM
Waters Kathleen AlyceChief Legal & Pub. Affairs OffMay 03Option Exercise75.7028,1642,132,01597,694May 04 08:24 PM
Waters Kathleen AlyceChief Legal & Pub. Affairs OffMay 03Sale118.365,290626,14669,530May 04 08:24 PM
Arway Pamela MDirectorMar 22Sale109.5143647,74619,239Mar 22 07:05 PM
DIAZ PAUL JDirectorNov 30Option Exercise68.7019,3581,329,92318,877Dec 02 06:31 PM
STAFFIERI MICHAEL DAVIDChief Operating Officer, DKCNov 30Sale109.7425,0002,743,51542,431Dec 02 06:31 PM
Arway Pamela MDirectorNov 20Sale107.8843046,38819,239Nov 23 07:22 PM
STAFFIERI MICHAEL DAVIDChief Operating Officer, DKCNov 18Option Exercise69.9267,1004,691,908132,576Nov 19 07:24 PM
STAFFIERI MICHAEL DAVIDChief Operating Officer, DKCNov 17Option Exercise75.4236,4772,751,095121,703Nov 19 07:24 PM
DESOER BARBARA JDirectorNov 17Sale111.001,388154,068430Nov 17 09:17 PM
Arway Pamela MDirectorNov 16Option Exercise68.7019,3581,329,92331,292Nov 17 09:15 PM
Arway Pamela MDirectorNov 16Sale111.637,326817,80119,669Nov 17 09:15 PM
DESOER BARBARA JDirectorNov 11Option Exercise68.173,816260,1533,816Nov 13 06:29 PM
Waters Kathleen AlyceChief Legal OfficerNov 10Sale105.0110,0001,050,12955,874Nov 12 06:17 PM